Tafenoquine and its derivatives as inhibitors for the severe acute respiratory syndrome coronavirus 2

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has severely affected human lives around the world as well as the global economy. Therefore, effective treatments against COVID-19 are urgently needed. Here, we screened a library containing Food and Drug Administrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yeh, Yang, Wen-Hao, Chen, Hsiao-Fan, Huang, Li-Min, Gao, Jing-Yan, Lin, Cheng-Wen, Wang, Yu-Chuan, Yang, Chia-Shin, Liu, Yi-Liang, Hou, Mei-Hui, Tsai, Chia-Ling, Chou, Yi-Zhen, Huang, Bao-Yue, Hung, Chian-Fang, Hung, Yu-Lin, Wang, Wei-Jan, Su, Wen-Chi, Kumar, Vathan, Wu, Yu-Chieh, Chao, Shih-Wei, Chang, Chih-Shiang, Chen, Jin-Shing, Chiang, Yu-Ping, Cho, Der-Yang, Jeng, Long-Bin, Tsai, Chang-Hai, Hung, Mien-Chie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800562/
https://www.ncbi.nlm.nih.gov/pubmed/35101449
http://dx.doi.org/10.1016/j.jbc.2022.101658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800562/
https://www.ncbi.nlm.nih.gov/pubmed/35101449
http://dx.doi.org/10.1016/j.jbc.2022.101658

Ejemplares similares